TORONTO, Sept. 9, 2015 - Eyecarrot Innovations Corp (EYC:CA) is pleased to announce the appointment of Bryce Salvador as Special Advisor, Product Development - High Performance and Athletics. Bryce will oversee the development of all products as it relates to their use in high performance and athletic training.
Bryce is the former captain of the New Jersey Devils who has just retired after playing 14 seasons in the NHL. He is also the CEO of xHockey Products, one of North America's leading eCommerce and retailers of performance hockey equipment, products, and training aids. Through a partnership with the Rockets Sports Group, located in Bridgewater, NJ, Bryce looks to build a flagship center of excellence in the Northeast for sports performance.
"Bryce brings his passion for development of athletes and prevention of injury through innovative methods to the Eyecarrot product suite. He adds experience and knowledge on expanding the vision, functionality, and scalability of our products for a global audience. His personal experiences, including using Vision Training as part of his rehabilitation from concussion injuries, as well as his extensive network and direct distribution channel should prove to be invaluable to us", commented Dr. Brent Norton, President and CEO of Eyecarrot.
Bryce Salvador stated, "I am excited to be a part of the Eyecarrot Team. After a cochlear concussion had left me sidelined for an entire hockey season, vision therapy along with sports vision training alleviated my visual symptoms and played a crucial role in my return to playing hockey in the NHL. Not only did the therapy help me recover from this injury, but it also enabled me to see the game in a way that I hadn't before. In joining Eyecarrot, I have the opportunity to use my first-hand experience to contribute to the development of Eyecarrot's high performance products for athletes and non-athletes alike".
Eyecarrot is Engineering Vision Science through Innovation and Big Data. We are building the BinoviTM Cloud, a universal system for testing and measuring a human's Oculomotor Sensory System performance.
On behalf of the Board of Directors
President & CEO
Telephone: 1.855.416.7158 - 416.943.6271
Forward looking information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Eyecarrot Innovations Corp.
For further information: Brent Norton, President & CEO, Telephone: 1.855.416.7158 - 416.943.6271
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer